Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Title HighNetWorth Traders Divided on Strykers Outlook

Based on the latest findings from the options scanner, an individual with substantial financial resources has adopted a pessimistic outlook on Stryker (NYSE:SYK) as of September 27, 2023. The sentiment among these high-net-worth traders is divided, with 36% expressing a bullish sentiment and 63% leaning towards a bearish stance.

Upon further analysis of the uncovered options, it has been observed that there are 10 put options valued at $465,475, indicating a bearish sentiment, and only 1 call option worth $43,130, suggesting a more optimistic perspective. These figures, combined with the Volume and Open Interest data associated with these contracts, suggest that influential investors have been focusing on a target price range of $250.0 to $270.0 for Stryker over the past three months.

In terms of overall options activity for Stryker on September 27, 2023, the mean open interest stands at 246.33, with a total volume of 3,591.00. These statistics provide further insight into the level of trading activity surrounding Stryker options on this particular day.

Stryker Corporation

SYK

Strong Buy

Updated on: 27/09/2023

Financial Health

Very Healthy


Debt to equity ratio: Buy

Price to earnings ratio: Strong Buy

Price to book ratio: Strong Buy

DCF: Strong Buy

ROE: Neutral

Show more

Price Target

Current $264.98

Concensus $279.52


Low $245.00

Median $280.00

High $311.00

Show more

Social Sentiments

We did not find social sentiment data for this stock

Analyst Ratings

Analyst / firm Rating
Matt O'Brien
Piper Sandler
Buy
Morgan Stanley Sell
Ryan Zimmerman
BTIG
Buy
Cowen Cowen
Cowen & Co.
Buy
Barclays Sell
Show more

SYK Stock Analysis: Strong Earnings and Revenue Growth in the Health Technology Sector

Stryker Corps Stock Performance Shows Strong Potential for Growth in 2023

On September 27, 2023, Stryker Corp’s stock performance was closely monitored by investors and analysts. With a median target price of $319.00, the stock was expected to see a significant increase of +20.20% from its last recorded price of $265.39. The consensus among 29 polled investment analysts was to buy stock in Stryker Corp, a rating that had remained steady since September. Stryker Corp, a leading medical technology company, had reported earnings per share of $2.40 for the current quarter. This strong financial performance was complemented by sales of $4.8 billion. Investors and market participants eagerly awaited the upcoming reporting date of October 26, when Stryker Corp would release its financial results for the quarter. Overall, the data and analysis from CNN Money indicated a positive sentiment towards Stryker Corp’s stock on September 27, 2023.

The post Title HighNetWorth Traders Divided on Strykers Outlook appeared first on Best Stocks.



This post first appeared on Best Stocks, please read the originial post: here

Share the post

Title HighNetWorth Traders Divided on Strykers Outlook

×

Subscribe to Best Stocks

Get updates delivered right to your inbox!

Thank you for your subscription

×